Real‐Time PCR of cytomegalovirus and Epstein–Barr virus in adult Egyptian patients with systemic lupus erythematosus
- 16 December 2013
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 18 (4), 452-458
- https://doi.org/10.1111/1756-185x.12261
Abstract
Infections may act as environmental triggers for induction of systemic lupus erythematosus (SLE). We sought to explore the relative frequencies of Epstein-Barr virus (EBV) and human cytomegalovirus (CMV) in adult Egyptian patients with SLE and their correlation with disease activity and damage. Thirty-three consecutive adult patients satisfying the 1997 American College of Rheumatology (ACR) Classification Criteria for SLE and 30 healthy controls were included in this case-control study. All patients were subjected to complete clinical and laboratory evaluation to determine the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR). Sera from both groups were analyzed for immunoglobulin M (IgM) and IgG antibodies against CMV and EBV. Qualitative real time polymerase chain reaction (PCR) for both viruses was performed for all SLE patients. Almost all SLE patients 32/33 (96.9%) were positive for IgG anti-CMV antibodies versus 20/30 in the control group (66.6%) (P = 0.002). All SLE patients were positive for IgG anti-EBV antibodies compared to 25 in the control group (100% vs. 83.3%, P = 0.02). CMV and EBV DNA were detected by PCR in 30.3% and 51.5% of SLE patients, respectively. A statistically significant lower SLEDAI was found in PCR positive patients for EBV compared to negative patients (9.6 ± 5.2 vs. 13.1 ± 3.1, respectively P = 0.041). Adult Egyptian patients with SLE had higher frequencies of anti-CMV and EBV IgG compared to healthy controls. Furthermore, our single point assessment of SLEDAI suggested that exposure to EBV infection might be associated with a lower disease activity.Keywords
This publication has 35 references indexed in Scilit:
- Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and CausationViruses, 2012
- Systemic lupus erythematosus: Clinical presentationsAutoimmunity Reviews, 2010
- Infections and autoimmunity: the multifaceted relationshipJournal of Leukocyte Biology, 2009
- Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodiesArthritis Research & Therapy, 2009
- Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activityMedical Microbiology and Immunology, 2007
- National Serosurvey of Cytomegalovirus in AustraliaClinical and Vaccine Immunology, 2006
- Human cytomegalovirus in patients with systemic lupus erythematosusAutoimmunity, 2005
- Detecting Epstein-Barr virus DNA from peripheral blood mononuclear cells in adult patients with systemic lupus erythematosus in TaiwanMedical Microbiology and Immunology, 2004
- Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphomaAnnals of Neurology, 1999
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992